SRC and breast carcinoma: Collectively, these results demonstrate that, in the context of ErbB2-driven breast cancer, c-Src loss reprograms bioenergetics and induces energy stress, reducing mTORC1 activity and thereby down-regulating the translation of PRC2 components.